Previous Close | 5.39 |
Open | 5.39 |
Bid | 5.50 x 1000 |
Ask | 5.52 x 900 |
Day's Range | 5.28 - 5.52 |
52 Week Range | 1.25 - 7.96 |
Volume | 53,367 |
Avg. Volume | 932,188 |
Market Cap | 142.911M |
Beta (5Y Monthly) | 2.35 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.99 |
Earnings Date | Feb 25, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 9.50 |
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Apollo Endosurgery...
AUSTIN, TX / ACCESSWIRE / March 19, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the terms of equity awards granted to Chas McKhann in connection with his appointment as the company's CEO in March 2021.
AUSTIN, TX / ACCESSWIRE / March 8, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the assignment of Category I Current Procedural Terminology (CPT®) codes with short form descriptor esophagogastroduodenoscopy with deployment of gastric bariatric device (e.